Carol A. Olson
Direktor/Vorstandsmitglied bei NellOne Therapeutics, Inc.
Profil
Carol A.
Olson is the founder of Churchill Madison Group.
She is currently a Director at NellOne Therapeutics, Inc. Her former positions include Director at Palo Alto Institute for Research & Education, Inc., Chief Commercial Officer & Senior Vice President at MedImmune Vaccines, Inc., Partner at Apax Partners, Inc., and Executive Vice President at Portola Pharmaceuticals, Inc. She received her undergraduate degree from Yale University and her MBA from Stanford Graduate School of Business.
Aktive Positionen von Carol A. Olson
| Unternehmen | Position | Beginn |
|---|---|---|
NellOne Therapeutics, Inc.
 NellOne Therapeutics, Inc. BiotechnologyHealth Technology NellOne Therapeutics, Inc. develops and produces soft-tissue regenerative medicine. It develops a new class of therapeutic products that will shift the paradigm of tissue healing after acute injury from scarring to complete regeneration of form and function. The company’s product NELL1 is a signaling protein that triggers pathways for tissue growth and maturation in a variety of tissues including heart muscle, skeletal muscle and blood vessels. NellOne Therapeutics was founded by Cymbeline Tancongco Culiat and Tracy S. Warren in 2008 and is headquartered in Oak Ridge, TN. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Carol A. Olson
| Unternehmen | Position | Ende |
|---|---|---|
Apax Partners, Inc.
 Apax Partners, Inc. Investment ManagersFinance Founded in 1976, Apax Partners, Inc. is a venture capital/private equity firm located in New York City. The firm is a subsidiary of London-based Apax Partners LLP | Private Equity Investor | 06.06.2005 |
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| Churchill Madison Group | Gründer | - |
| Palo Alto Institute for Research & Education, Inc. | Direktor/Vorstandsmitglied | - |
MedImmune Vaccines, Inc.
 MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Corporate Officer/Principal | - |
Ausbildung von Carol A. Olson
| Yale University | Undergraduate Degree |
| Stanford Graduate School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Apax Partners, Inc.
Apax Partners, Inc. Investment ManagersFinance Founded in 1976, Apax Partners, Inc. is a venture capital/private equity firm located in New York City. The firm is a subsidiary of London-based Apax Partners LLP | Finance |
NellOne Therapeutics, Inc.
NellOne Therapeutics, Inc. BiotechnologyHealth Technology NellOne Therapeutics, Inc. develops and produces soft-tissue regenerative medicine. It develops a new class of therapeutic products that will shift the paradigm of tissue healing after acute injury from scarring to complete regeneration of form and function. The company’s product NELL1 is a signaling protein that triggers pathways for tissue growth and maturation in a variety of tissues including heart muscle, skeletal muscle and blood vessels. NellOne Therapeutics was founded by Cymbeline Tancongco Culiat and Tracy S. Warren in 2008 and is headquartered in Oak Ridge, TN. | Health Technology |
MedImmune Vaccines, Inc.
MedImmune Vaccines, Inc. BiotechnologyHealth Technology MedImmune Vaccines, Inc. develops, manufactures and markets live vaccines. Its developed vaccine is inhaled FluMist. The company is located in Mountain View, CA | Health Technology |
| Palo Alto Institute for Research & Education, Inc. | |
| Churchill Madison Group | |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
